Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
Microsoft
MSFT
|
+$667M |
| 3 |
Spotify
SPOT
|
+$528M |
| 4 |
iShares Bitcoin Trust
IBIT
|
+$438M |
| 5 |
Eli Lilly
LLY
|
+$412M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.59B |
| 2 |
Amazon
AMZN
|
+$1.45B |
| 3 |
Merck
MRK
|
+$925M |
| 4 |
Broadcom
AVGO
|
+$765M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$672M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.59% |
| 2 | Healthcare | 7.29% |
| 3 | Financials | 7.2% |
| 4 | Industrials | 6.32% |
| 5 | Consumer Discretionary | 4.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5201
PUT
Relmada Therapeutics
RLMD
$562M
| $243K | ﹤0.01% |
+75,000
| New | +$243K |
|
5202
PUT
Rollins
ROL
$18.5B
| $243K | ﹤0.01% |
+4,800
| New | +$237K |
|
5203
TScan Therapeutics
TCRX
$49.4M
| $242K | ﹤0.01% |
48,672
+20,783
| +75% | +$125K |
|
5204
Amerant Bancorp
AMTB
$1.16B
| $242K | ﹤0.01% |
+11,327
| New | +$249K |
|
5205
VinFast Auto
VFS
$7.25B
| $242K | ﹤0.01% |
63,319
+42,627
| +206% | +$169K |
|
5206
PUT
Macerich
MAC
$7.22B
| $241K | ﹤0.01% |
+13,200
| New | +$208K |
|
5207
Century Therapeutics
IPSC
$395M
| $241K | ﹤0.01% |
140,759
-237,874
| -63% | -$466K |
|
|
MRCC
5208
DELISTED
Monroe Capital Corp
MRCC
| $240K | ﹤0.01% |
+29,716
| New | +$229K |
|
|
NFGC
5209
New Found Gold
NFGC
$549M
| $240K | ﹤0.01% |
94,845
-55,598
| -37% | -$153K |
|
5210
Praxis Precision Medicines
PRAX
$8.58B
| $240K | ﹤0.01% |
4,169
-86,740
| -95% | -$4.69M |
|
5211
Alector
ALEC
$180M
| $239K | ﹤0.01% |
51,218
-105,562
| -67% | -$566K |
|
5212
CALL
SolarEdge
SEDG
$2.54B
| $238K | ﹤0.01% |
10,400
-1,800
| -15% | -$43.8K |
|
5213
Kodak
KODK
$819M
| $238K | ﹤0.01% |
50,479
-152,166
| -75% | -$792K |
|
5214
iShares US Tech Independence Focused ETF
IETC
$663M
| $238K | ﹤0.01% |
+3,040
| New | +$228K |
|
5215
Bioceres Crop Solutions
BIOX
$21.4M
| $238K | ﹤0.01% |
+30,249
| New | +$305K |
|
5216
CALL
Toast
TOST
$19.1B
| $238K | ﹤0.01% |
8,400
-17,100
| -67% | -$433K |
|
5217
Destination XL Group
DXLG
$29.3M
| $237K | ﹤0.01% |
80,606
+31,901
| +65% | +$99.3K |
|
|
SRTA
5218
Strata Critical Medical Inc
SRTA
$440M
| $237K | ﹤0.01% |
80,542
-14,035
| -15% | -$44.7K |
|
5219
CALL
Gen Digital
GEN
$16.3B
| $236K | ﹤0.01% |
8,600
-12,500
| -59% | -$321K |
|
|
5220
PUT
Gen Digital
GEN
$16.3B
| $236K | ﹤0.01% |
+8,600
| New | +$221K |
|
5221
PUT
Capricor Therapeutics
CAPR
$243M
| $236K | ﹤0.01% |
+15,500
| New | +$76.7K |
|
5222
CALL
Arch Capital
ACGL
$34.5B
| $235K | ﹤0.01% |
+2,100
| New | +$218K |
|
|
5223
PUT
Arch Capital
ACGL
$34.5B
| $235K | ﹤0.01% |
2,100
-3,000
| -59% | -$312K |
|
5224
B&G Foods
BGS
$293M
| $235K | ﹤0.01% |
26,427
-46,864
| -64% | -$397K |
|
5225
Vanguard ESG International Stock ETF
VSGX
$6.53B
| $234K | ﹤0.01% |
+3,797
| New | +$224K |
|
Similar funds
Millennium Management's Q3 2024 Portfolio in Review
As of Q3 2024, Millennium Management held 6,698 positions worth $211B, down 2.3% from $216B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Millennium Management withdrew a net $20.6B in Q3 2024, closing 667 positions and reducing 2,445 holdings. Its most notable exit was WestRock Company, an estimated $161M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.6% of assets, down from 10% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Smurfit Westrock worth $94.1M.
- Millennium Management's largest Q3 2024 buy was Smurfit Westrock: 1,904,931 shares worth $94.1M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $1.38B increase.
- Millennium Management's biggest Q3 2024 reduction was Apple, cutting an estimated $2.59B.
- Millennium Management fully exited WestRock Company in Q3 2024, selling an estimated $161M.
- Millennium Management's ten largest holdings make up 17% of its $211B portfolio in Q3 2024.
- Millennium Management opened 898 new positions and closed 667 in Q3 2024.
- Millennium Management's portfolio value fell 2.3% quarter-over-quarter to $211B.
Based on Millennium Management's 13F filing for Q3 2024, filed 14 Nov 2024.